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Cabeza (caz) is the single Drosophila melanogaster orthologue of the human FET proteins FUS, TAF15, and EWSR1, which 
have been implicated in amyotrophic lateral sclerosis (ALS) and frontotemporal dementia. In this study, we identified 
Xrp1, a nuclear chromatin-binding protein, as a key modifier of caz mutant phenotypes. Xrp1 expression was strongly 
up-regulated in caz mutants, and Xrp1 heterozygosity rescued their motor defects and life span. Interestingly, selective 
neuronal Xrp1 knockdown was sufficient to rescue, and neuronal Xrp1 overexpression phenocopied caz mutant phenotypes. 
The caz/Xrp1 genetic interaction depended on the functionality of the AT-hook DNA-binding domain in Xrp1, and the 
majority of Xrp1-interacting proteins are involved in gene expression regulation. Consistently, caz mutants displayed 
gene expression dysregulation, which was mitigated by Xrp1 heterozygosity. Finally, Xrp1 knockdown substantially 
rescued the motor deficits and life span of flies expressing ALS mutant FUS in motor neurons, implicating gene expression 
dysregulation in ALS-FUS pathogenesis.
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Introduction
Amyotrophic lateral sclerosis (ALS) is an adult-onset neurode-
generative disorder characterized by motor neuron loss, leading 
to progressive muscle weakness and ultimately complete paraly-
sis and death (Taylor et al., 2016). Mutations in several genes en-
coding RNA-binding proteins (RBPs) cause familial ALS (FALS), 
including TDP-43 (Gitcho et al., 2008; Kabashi et al., 2008; 
Sreedharan et al., 2008), FUS (Kwiatkowski et al., 2009; Vance 
et al., 2009), TAF15 (Couthouis et al., 2011), EWSR1 (Couthouis 
et al., 2012), hnRNPA1 and hnRNPA2B1 (Kim et al., 2013b), and 
matrin-3 (Johnson et al., 2014). Furthermore, TDP-43–positive 
inclusions are found in most sporadic ALS patients (Neumann 
et al., 2006; Taylor et al., 2016), and inclusions containing either 
TDP-43 or FUS are a pathological hallmark in ∼45% and ∼10% of 
patients with frontotemporal dementia (FTD), respectively (Ling 
et al., 2013). These findings implicated defects in RNA biogenesis 
in ALS and FTD pathogenesis.
Of the ALS-associated RBPs, FUS, EWSR1, and TAF15 (FET) 
proteins are highly homologous proteins that constitute the FET 
family (Schwartz et al., 2015). The FET proteins are DNA-bind-
ing proteins and RBPs involved in gene expression regulation, 
including transcription, mRNA splicing, and mRNA subcellular 
localization (Schwartz et al., 2015). Heterozygous mutations in 
FUS account for ∼5% of FALS (Ling et al., 2013), while mutations 
in TAF15 and EWSR1 are rare (Couthouis et al., 2011, 2012). Most 
ALS-associated mutations cluster in the nuclear localization sig-
nal of FUS, resulting in a shift from a predominantly nuclear to a 
more cytoplasmic localization, formation of cytoplasmic aggre-
gates, and reduced nuclear FUS levels (Da Cruz and Cleveland, 
2011). This suggests that loss of nuclear FUS function may con-
tribute to ALS pathogenesis, although evidence from ALS-FUS 
mouse models indicates that ALS-FUS mutations also result in 
a novel toxic function that triggers motor neuron degeneration 
(Scekic-Zahirovic et al., 2016, 2017; Sharma et al., 2016). More-
over, in FTD with FUS pathology (FTLD-FUS), the three FET pro-
teins are found in pathogenic inclusions, with reduced levels or 
complete loss of nuclear FET proteins in inclusion-bearing cells, 
indicating that loss of nuclear FET function may contribute to 
FTLD-FUS (Neumann et al., 2011; Davidson et al., 2013).
The Drosophila melanogaster gene cabeza (caz) encodes 
the single fly orthologue of the three human FET proteins. Ac-
cordingly, Caz is a predominantly nuclear RBP that contains 
the functional domains of the human FET proteins (Schwartz 
et al., 2015). When expressed in mammalian cells, Caz elicits 
down-regulation of FUS protein levels (Immanuel et al., 1995), 
while FUS expression in Drosophila rescues caz mutant pheno-
types (Wang et al., 2011), indicating functional homology. We 
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previously generated caz mutant animals, which exhibit pupal 
lethality because adult flies fail to eclose due to motor deficits 
(Frickenhaus et al., 2015). In this study, we performed a genetic 
screen to gain insight into the molecular mechanisms under-
lying caz mutant phenotypes. Exhaustive screening of ∼80% 
of the Drosophila genome identified Xrp1 as the only gene for 
which heterozygosity could rescue caz mutant phenotypes. Xrp1 
encodes a protein containing an AT-hook DNA-binding domain 
often found in proteins involved in chromatin remodeling, 
transcriptional regulation, and DNA repair (Reeves, 2010). Xrp1 
expression was increased in caz mutants, and neuron-selective 
knockdown of Xrp1 was sufficient to rescue caz mutant pheno-
types. Importantly, the DNA-binding capacity of the AT-hook do-
main of Xrp1 was required to mediate caz mutant phenotypes, 
and caz mutants displayed substantial gene expression dysreg-
ulation, which was significantly mitigated by heterozygosity for 
Xrp1. Finally, Xrp1 knockdown in motor neurons rescued pheno-
types induced by ALS mutant FUS expression, underscoring the 
potential relevance of our findings for human disease. Together, 
we propose that caz mutant phenotypes are mediated by up-reg-
ulation of Xrp1, leading to gene expression dysregulation and 
neuronal dysfunction.
Results
A genetic screen to identify suppressors of caz 
mutant phenotypes
We previously generated two independent caz null alleles: 
(1) caz2, an imprecise excision allele, and (2) cazKO, generated 
by homologous recombination (Frickenhaus et al., 2015). Caz 
mutants die during the pupal stage due to motor incapability 
resulting in pharate adults failing to eclose from the pupal case. 
This phenotype was used to perform a dominant suppressor 
screen whereby males carrying chromosomal deficiencies were 
crossed to caz2 heterozygous females. Since caz is on the X chro-
mosome, this approach allowed us to screen for genes on the 
second and third chromosomes for which hemizygosity would 
rescue the pupal lethality of caz2 males (Fig. 1 A). This screen 
yielded only a single deficiency that rescued caz2 pupal lethality, 
Df(3R)ED2 (Fig. 1 B).
Fine mapping using smaller overlapping deficiencies reduced 
the number of candidate genes to 11 (Fig. 1 C). As Df(3R)Exel6181 
and Df(3R)Exel6182 are neighboring but nonoverlapping defi-
ciencies that have a common break point in Xrp1, the fact that 
heterozygosity for either of these deficiencies rescued caz2 pupal 
lethality suggested that heterozygous loss of Xrp1 may mediate 
the rescue (Fig. 1, B and C).
Heterozygosity for Xrp1 rescues caz mutant pupal lethality
Xrp1 is predicted to encode seven alternative transcripts (Fig. S1 
A), four of which can be translated into a 668-aa “long” isoform 
(Xrp1Long) and the remaining three into a 406-aa “short” isoform 
(Xrp1Short). We generated two Xrp1 deletion alleles: Df(3R)Xrp1Plus 
is a ∼25-kb deletion of Xrp1, Mpc1, and part of CG42613 (Fig. 1 D), 
whereas Xrp1Ex-long selectively deletes two thirds of Xrp1, ex-
pected to abolish expression of all Xrp1Long transcripts, but pos-
sibly leaving expression of a Xrp1Short transcript (Xrp1-RD) intact 
(Fig. 1 E). In addition, we used in vivo homologous recombination 
to generate the Xrp1KO allele, in which the entire Xrp1 coding re-
gion is precisely deleted (Figs. 1 F and S1 C).
All three Xrp1 mutant alleles were homozygous viable, and 
quantitative PCR (qPCR) using primers that selectively detect Xr-
p1Long revealed loss of Xrp1Long transcript in homozygous Df(3R)
Xrp1Plus, Xrp1Ex-long, and Xrp1KO animals (Fig. 1 G). qPCR using 
primers detecting all Xrp1 isoforms revealed loss of Xrp1 tran-
script in Df(3R)Xrp1Plus and Xrp1KO flies, whereas in Xrp1Ex-long 
flies, some residual Xrp1 transcript could be detected (∼8% of WT 
levels), presumably reflecting expression of the short Xrp1-RD 
mRNA isoform (Fig. 1 H).
Crossing males heterozygous for either Df(3R)Xrp1Plus, 
Xrp1Ex-long, or Xrp1KO to caz2/FM7 or cazKO/FM7 females revealed 
that heterozygosity for Df(3R)Xrp1Plus or Xrp1KO rescued caz 
mutant pupal lethality to a similar extent as Xrp1 deficiencies 
and a genomic caz transgene, independent of the caz null allele 
used (Fig. 1, I and J). Heterozygosity for Xrp1Ex-long only partially 
rescued, presumably due to residual Xrp1 expression (Fig. 1, I 
and J). Furthermore, the mild rough eye phenotype previously 
reported in caz mutant adult escaper flies (Wang et al., 2011) 
was rescued by Xrp1 heterozygosity. While a genetic interaction 
was previously reported between caz and TBPH, the Drosoph-
ila homologue of TAR DBP, encoding TDP-43 (Wang et al., 2011), 
Xrp1 heterozygosity could not rescue the adult eclosion defect of 
TBPH mutants (Fig. S2). Thus, loss of 50% of Xrp1 gene dosage 
is sufficient to rescue pupal lethality induced by loss of caz but 
not TBPH function.
Xrp1 heterozygosity rescues motor deficits and life span of 
caz mutant flies
As caz mutant flies display motor defects (Wang et al., 2011; 
Frickenhaus et al., 2015), we evaluated motor performance of 
caz mutant Xrp1 heterozygous flies using an automated negative 
geotaxis climbing assay (Niehues et al., 2015). While we failed 
to obtain caz mutant adult escapers, Xrp1 heterozygous caz mu-
tant flies managed to climb the wall of a test vial, although their 
climbing speed was still significantly reduced as compared with 
control animals (Fig. 2 A). Analysis of larval locomotion revealed 
that caz mutant third instar larvae display a significantly re-
duced crawling speed, which was fully rescued by heterozygosity 
for Xrp1 (Fig. S3 A).
Evaluation of life span revealed that Xrp1 heterozygosity re-
sulted in a substantial rescue of life span as compared with pupal 
lethality of caz2 and cazKO flies, although the life span of rescued 
caz mutants was still shorter than control flies (Fig. 2 B). Thus, 
heterozygosity for Xrp1 partially but substantially rescues caz 
mutant motor performance and life span.
Selective knockdown of Xrp1 in neurons rescues caz 
mutant phenotypes
Selective reintroduction of Caz in neurons was shown to rescue 
caz mutant phenotypes (Wang et al., 2011; Frickenhaus et al., 
2015), while selective inactivation of caz in neurons resulted 
in severe motor deficits and reduced life span (Frickenhaus 
et al., 2015), indicating that loss of caz function in neurons is 
both necessary and sufficient to induce caz mutant phenotypes. 
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We therefore evaluated whether selective knockdown of Xrp1 
in neurons was sufficient to rescue caz mutant phenotypes de-
spite the fact that the FlyAtlas and modENC ODE databases re-
port Xrp1 expression in all tissues throughout development and 
adult life. Two independent transgenic Xrp1-RNAi lines revealed 
that selective knockdown of Xrp1 in neurons (elav-GAL4) fully 
rescued caz mutant pupal lethality (Fig. 2 C) and partially res-
cued caz mutant motor performance for cazKO even to a similar 
extent as neuronal Caz reintroduction (Fig. 2 D). Importantly, 
selective knockdown of Xrp1 in motor neurons (D42-GAL4) 
was sufficient to fully rescue the reduced crawling speed of caz 
mutant larvae (Fig. S3 B), indicating that the larval locomotion 
deficit is attributable to dysfunction of motor neurons. Finally, 
the median life span of caz mutant flies with neuronal Xrp1 
knockdown ranged from 30% to 50% of the life span of their 
respective controls (Fig. 2, E and F), comparable with the life 
span of Xrp1 heterozygous caz mutants. To evaluate the level of 
knockdown induced by the two Xrp1-RNAi lines, qPCR revealed 
residual Xrp1 transcript levels in the central nervous system 
(CNS) of actin5C-GAL4>UAS-Xrp1-RNAi third instar larvae of 
∼7% and ∼11% of control levels for UAS-Xrp1-RNAi-1 and UAS-
Xrp1-RNAi-2, respectively (Fig. S1 B). Furthermore, selective 
Xrp1 knockdown in glial cells did not rescue caz mutant pupal 
lethality (Fig. S4 A). Together, these findings demonstrate that 
selective down-regulation of Xrp1 in neurons is sufficient to res-
cue caz mutant phenotypes.
Figure 1.  Heterozygosity for Xrp1 rescues 
caz mutant pupal lethality. (A) Screening 
strategy to identify chromosomal deficiencies 
that rescue caz2 pupal lethality. (B) Frequency 
of adult male offspring from the indicated cross 
that is heterozygous for a genomic caz transgene 
or the indicated deficiencies. n > 128 per geno-
type. ***, P < 0.0001; χ2 test. (C) Genomic region 
uncovered by Df(3R)ED2. Pink indicates genes 
in the plus orientation; white indicates genes in 
the minus orientation. The different smaller defi-
ciencies within this region which were tested for 
rescue of caz2 pupal lethality are shown. Check 
marks indicate deficiencies that rescue; X marks 
indicate deficiencies that do not rescue. (D–F) 
Xrp1 genomic locus showing the insertion sites 
of the transposable elements used to generate 
Xrp1 mutant alleles. In the Df(3R)Xrp1Plus allele 
(D), Xrp1, Mpc1, and the 5′ end of CG42613 are 
deleted. In the Xrp1Ex-long allele (E), the 5′ half of 
Xrp1 is deleted, predicted to abolish expression 
of the Xrp1Long isoform. The Xrp1Short isoform, 
encoded by Xrp1-RD, may still be expressed. 
In the Xrp1KO allele (F), the Xrp1 coding region 
is precisely deleted. (G and H) Xrp1 transcript 
levels in Xrp1 mutant lines relative to WT con-
trols (100%) determined by qPCR using primers 
either selectively detecting Xrp1Long transcripts 
(G) or detecting all Xrp1 transcripts (H). n = 10. 
***, P < 0.0001; one-way ANO VA. Mean ± SEM. 
(I and J) Frequency of adult male offspring from 
the indicated crosses that is heterozygous for the 
indicated Xrp1 allele. n > 87 per genotype. *, P < 
0.05; ***, P < 0.0001; χ2 test.
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Increased Xrp1 expression mediates caz mutant phenotypes
Our finding that reducing Xrp1 expression rescues caz mutant 
phenotypes raised the possibility that these phenotypes are 
caused by up-regulation of Xrp1 expression, with particularly 
deleterious effects in neurons. Consistent with this hypothesis, 
qPCR revealed that Xrp1 mRNA levels are increased three- to 
fourfold in both CNS and body wall of caz mutants (Figs. 3 A and 
S4, B and C). Remarkably, in caz mutant Xrp1 heterozygotes, Xrp1 
transcript levels were not significantly different from controls 
(Fig. 3 A). Thus, phenotypic rescue of caz mutants by Xrp1 het-
erozygosity is associated with normalization of Xrp1 expression 
levels. Vice versa, ubiquitous caz overexpression from the adult 
stage onwards did not reduce Xrp1 mRNA levels (Fig. 3 B). To 
evaluate whether Xrp1 gene dosage modifies caz expression lev-
els, qPCR and Western blotting was performed on Xrp1 mutants 
and transgenic flies ubiquitously overexpressing Xrp1Long or 
Xrp1Short. These analyses revealed that Caz levels are not signifi-
cantly changed in Xrp1 mutants (Fig. 3, C, E, and F) or upon Xrp1 
overexpression (Fig. 3 D). Thus, loss of caz increases Xrp1 expres-
sion, but Caz overexpression does not down-regulate Xrp1, and 
alteration of Xrp1 levels has no effect on caz expression.
To further test the hypothesis that increased Xrp1 expression 
in neurons is a key mediator of caz mutant phenotypes, we eval-
uated the effect of selective Xrp1 overexpression in neurons of 
otherwise WT flies. Neuronal overexpression of either Xrp1Long 
or Xrp1Short induced developmental lethality, with a fraction of 
adult escapers emerging (Figs. 3 G and S4 D). These adult escap-
ers displayed substantial motor performance deficits (Figs. 3 H 
and S4 E) and a significantly shortened life span (Figs. 3 I and S4 
F). Thus, neuronal Xrp1 overexpression phenocopies caz mutant 
phenotypes. Together with the findings that Xrp1 heterozygos-
ity or Xrp1 neuronal knockdown rescue caz mutant phenotypes, 
these results indicate that increased neuronal Xrp1 levels medi-
ate caz mutant phenotypes.
Xrp1 is a nuclear protein that binds chromatin
The Xrp1 protein is predicted to contain two conserved 
DNA-binding domains in its C terminus: (1) an AT-hook motif 
consisting of nine amino acids centered on the invariant tripep-
tide glycine-arginine-proline (Reeves, 2010) and (2) a basic-re-
gion leucine zipper (bZIP) motif found in the bZIP family of 
transcription factors, which typically consists of a basic region of 
∼20 aa that mediates sequence-specific DNA binding along with 
a leucine zipper, a sequence of 40–60 hydrophobic amino acids 
in which leucine occurs every seventh residue, which mediates 
dimerization (Vinson et al., 2002). Despite the fact that Xrp1 was 
reported to heterodimerize with the bZIP protein Irbp18 (Francis 
et al., 2016), coimmunoprecipitation experiments on extracts of 
Figure 2.  Rescue of caz mutant pheno-
types by Xrp1 heterozygosity or by selective 
knockdown of Xrp1 in neurons. (A) Average 
climbing speed in an automated negative geo-
taxis assay of heterozygous Df(3R)Xrp1Plus male 
flies (control) and caz mutant males rescued by 
genomic caz or heterozygosity for Xrp1. n > 100 
per genotype. ***, P < 0.0005; Mann-Whitney 
test. Mean ± SEM. (B) Life span of WT (control), 
Df(3R)Xrp1Plus heterozygous, and caz mutant 
male flies rescued by genomic caz or heterozy-
gosity for Xrp1. n = 78–127 per genotype. (C) Fre-
quency of adult male offspring from the indicated 
cross that carries UAS-caz, UAS-Xrp1-RNAi, or no 
UAS transgene (control). n > 176 per genotype. 
***, P < 0.0001; χ2 test. (D) Average climbing 
speed of adult male control (driver-only) flies, 
flies with neuronal (elav-GAL4) Xrp1 knockdown, 
and caz mutants rescued by neuronal Caz or neu-
ronal Xrp1 knockdown. n > 100 per genotype. 
*, P < 0.05; **, P < 0.01; Mann-Whitney test. 
Mean ± SEM. (E and F) Life span of male flies 
selectively expressing caz or Xrp1-RNAi in neu-
rons either in a WT, caz2 (E), or cazKO (F) back-
ground. n = 76–164 per genotype.
Mallik et al. 
Xrp1 mediates caz mutant phenotypes
Journal of Cell Biology
https://doi.org/10.1083/jcb.201802151
5
Drosophila S2 cells cotransfected with N-terminal HA-tagged 
and Flag-tagged variants of either Xrp1Long or Xrp1Short indicated 
that Xrp1 does not homodimerize (Fig. S4, G and H).
As Ensembl and NCBI Blastp searches failed to identify a 
human Xrp1 orthologue, we used HHpred (Zimmermann et 
al., 2018), the most sensitive homology detection tool, to iden-
tify human Xrp1 homologues. This yielded human homologues 
for the C-terminal ∼150 aa of Xrp1 that contain the conserved 
DNA-binding domains (Table S1). Although these human pro-
teins all contain a bZIP domain, they do not appear to be Xrp1 
orthologues, as reciprocal searches against Drosophila proteins 
using HHpred with the “best hits” from human, a reliable method 
to detect orthologues whose sequence homology is not apparent 
with pairwise searches (Szklarczyk et al., 2012), did not uncover 
Xrp1. Furthermore, none of the human Xrp1 homologues con-
tained an AT-hook motif, and in fact, none of the bZIP proteins 
in the SMA RT database (Letunic and Bork, 2018) contained 
an AT-hook motif.
Consistent with the presence of two putative DNA-binding 
domains and its reported roles in protection against genotoxic 
stress and DNA repair (Brodsky et al., 2004; Akdemir et al., 
2007; Francis et al., 2016), subcellular localization experiments 
revealed that Xrp1 is localized to the nucleus, where it colocalizes 
with Caz, both in Drosophila S2R+ cells and in motor neurons in 
vivo (Fig. 4, A–C). To evaluate whether Xrp1 binds chromatin, im-
munostaining for Xrp1 was performed on polytene chromosomes 
from larval salivary glands. Xrp1 was found to preferentially 
localize to euchromatic bands and to “puffs,” enlarged regions 
Figure 3.  Xrp1 expression is up-regulated 
in caz mutants, and selective neuronal Xrp1 
overexpression phenocopies caz mutant 
phenotypes. (A) Xrp1 transcript levels as deter-
mined by qPCR on CNS of WT, caz mutant, Xrp1 
heterozygous, and caz mutant Xrp1 heterozy-
gous larvae. n = 10. (B) Xrp1 transcript levels 
in heads of adult male flies that ubiquitously 
(tub-GAL4) overexpress Caz, Xrp1Long, Xrp1Short, 
or no transgene (control) from the adult stage 
onwards. n = 10. (C) Caz transcript levels in lar-
val CNS of WT and two Xrp1 mutants. n = 10. 
(D) Caz transcript levels in heads of adult male 
flies that ubiquitously overexpress caz, Xrp1Long, 
Xrp1Short, or no transgene (control) from the adult 
stage onwards. n = 10. ***, P < 0.0001; one-way 
ANO VA. (E) Representative Western blot to 
evaluate Caz protein levels in larval CNS from 
WT, caz mutants, and Xrp1 mutants. β-tubulin 
was used as loading control. (F) Quantification 
of Caz protein levels relative to β-tubulin. n = 5. 
P = NS; one-way ANO VA. (G) Frequency of adult 
male offspring from the indicated cross. n > 111 
per genotype. ***, P < 0.0005; χ2 test. (H) Aver-
age climbing speed of adult male flies selectively 
overexpressing Xrp1Short in neurons (elav-GAL4) 
as compared with driver-only controls. n > 100 
per genotype. ***, P < 10−9; Mann-Whitney test. 
(I) Life span of male flies selectively overexpress-
ing Xrp1Short in neurons (elav-GAL4) as compared 
with driver-only controls. n = 77–102. All graphs 
display mean ± SEM.
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which indicate sites of active transcription (Fig. 4 D), suggesting 
a possible involvement of Xrp1 in regulation of gene expression. 
Furthermore, Xrp1 also localized to centromeric β-heterochro-
matin (Fig. 4 D). Caz prominently localized to puffs on polytene 
chromosomes (Fig. 4 E), and overall, Caz and Xrp1 displayed a 
distinct binding pattern with some overlap (e.g., arrowhead in 
Fig. 4, D and E).
Xrp1-interacting proteins suggest a role in gene 
expression regulation
To obtain a comprehensive overview of the molecular processes 
in which Xrp1 may be involved, we immunoprecipitated N-ter-
minal Flag-tagged Xrp1 (either short or long isoform) from 
Drosophila S2 cells and identified interacting proteins by mass 
spectrometry (MS; Fig. 5 A). 106 Xrp1long-interacting proteins 
and 40 Xrp1short-interacting proteins were identified (Tables S2 
and S3). The substantially higher number of Xrp1long-interact-
ing proteins is likely attributable to its 262 additional N-terminal 
amino acids. Importantly, of the 40 Xrp1short-interacting proteins, 
33 were also identified as Xrp1long-interacting proteins (Fig. 5 B). 
In addition, consistent with heterodimer formation between 
Xrp1 and Irbp18 (Francis et al., 2016), Irbp18 was identified as an 
Xrp1-interacting protein (Fig. 5 C and Table S2). Remarkably, out 
of a total of 112 Xrp1-interacting proteins, 62 (55.4%) are involved 
in gene expression regulation or DNA/RNA metabolism, includ-
ing regulation of transcription (15), chromatin organization (12), 
DNA metabolism (9), DNA repair (5), RNA metabolism (14), and 
DNA-binding proteins (3) and RBPs (4; Fig. 5 C).
Figure 4.  Xrp1 is a nuclear protein that 
binds chromatin. (A) Immunostaining of 
Drosophila S2R+ cells expressing N-terminal 
HA-tagged Xrp1Short for lamin (labels the nuclear 
membrane), and the HA tag revealed Xrp1 local-
ization to the nucleus (top). Immunostaining 
for Caz and HA::Xrp1 showed colocalization 
(bottom). (B) HA-tagged Xrp1 was selectively 
expressed in larval motor neurons (OK371-GAL4). 
Immunostaining for lamin and HA::Xrp1 revealed 
nuclear localization. Control animals are driver 
only. (C) HA-tagged Xrp1 was coexpressed with 
membrane-bound GFP in larval motor neurons. 
Immunolabeling for Caz and HA::Xrp1 showed 
colocalization of Caz and Xrp1. Control animals 
do not express HA::Xrp1. (D and E) Immunos-
taining of Xrp1 (D) or Caz (E) on polytene chro-
mosomes. Chromatin was counterstained with 
DAPI. Xrp1 prominently localizes to euchro-
matic bands (arrows indicate examples), to puffs 
(arrowheads), and to centromeric β-heteroch-
romatin (asterisks). Caz prominently localizes 
to puffs. Overall, Caz and Xrp1 display a distinct 
binding pattern, although there is some overlap, 
e.g., the puff region indicated by an arrowheads in 
D and E. Bars: 10 µm (A); 20 µm (B–E).
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Following a similar experimental approach, we immuno-
precipitated endogenous Caz from S2 cells and identified 88 
Caz-interacting proteins (Table S4). Remarkably, 58 of these pro-
teins (65.9%) were also identified as Xrp1-interacting proteins 
(Fig. 5 B), suggesting that Caz and Xrp1 are involved in similar 
molecular processes and/or commonly reside in protein com-
plexes. The latter possibility is unlikely, as Caz did not coimmu-
noprecipitate with Xrp1 (Fig. S4 I).
The caz-Xrp1 genetic interaction depends on the functionality 
of the AT-hook domain of Xrp1
We next wanted to evaluate whether the rescue of caz mutant 
phenotypes by Xrp1 heterozygosity depends on the functional-
ity of the AT-hook DNA-binding domain of Xrp1. We therefore 
evaluated whether a mild increase of Xrp1 levels in “rescued” 
Xrp1 heterozygous caz mutant flies would revert the rescue and 
result in pupal lethality, and if so, whether expression of Xrp1 
with a subtle mutation in the AT-hook motif that precludes DNA 
binding would still revert the rescue.
As neuron-selective expression of Xrp1 from the standard 
pUAST transgenesis vector induces phenotypes by itself (Fig. 3, 
G–I; and Fig. S4, D–F), we used a modified pUAST vector with 
only three UAS sites, known to result in lower transgene ex-
pression levels (Fig.  6  A; Pfeiffer et al., 2010). The resulting 
3×UAS-Xrp1 lines did not induce developmental lethality when 
selectively expressed in neurons (elav-GAL4; Fig. 6 C). Neuronal 
Xrp1 expression from 3×UAS transgenes was nevertheless able 
to revert the rescue of caz mutant pupal lethality by Xrp1 hetero-
zygosity (Fig. 6, D and E). We therefore inactivated the Xrp1 AT-
hook domain in the 3×UAS constructs by mutagenizing the RGR 
triplet of the KRK RGR PAK motif to AAA, known to abolish AT-
hook–mediated DNA binding (Fig. 6 B; Metcalf and Wassarman, 
2006; Turlure et al., 2006; Baker et al., 2013). The subtle AT-hook 
mutation altered the binding pattern of Xrp1 on polytene chro-
mosomes (Fig. S3 C) but did not reduce the stability of the Xrp1 
protein and in fact increased Xrp1 protein level (Fig. S1, D–F). In 
spite of this, AT-hook–mutant UAS-Xrp1 transgenes were no lon-
ger able to revert the rescue of caz mutant pupal lethality by Xrp1 
heterozygosity (Fig. 6, D and E). These data demonstrate that the 
genetic interaction between caz and Xrp1 is dependent on the 
functionality of the AT-hook DNA-binding motif in Xrp1.
Gene expression dysregulation in caz mutants is rescued by 
Xrp1 heterozygosity
FUS is known to be involved in transcriptional regulation and 
mRNA splicing (Schwartz et al., 2012, 2015; Tan et al., 2012; Yang 
Figure 5.  Identification of Xrp1- and 
Caz-interacting proteins. (A) Approach used 
to identify Xrp1-interacting proteins. N-terminal 
Flag-tagged Xrp1 was expressed in Drosophila 
S2 cells. Coimmunoprecipitation followed by 
quantitative MS was used to identify Xrp1-inter-
acting proteins, defined as proteins significantly 
enriched in Flag::Xrp1-expressing cells as com-
pared with control cells. (B) Venn diagrams illus-
trating the substantial overlap between Xrp1Long-, 
Xrp1Short-, and Caz-interacting proteins. (C) The 
majority (55.4%) of Xrp1-interacting proteins are 
involved in gene expression regulation or DNA/
RNA metabolism, including regulation of tran-
scription, chromatin organization, DNA metabo-
lism, DNA repair, RNA metabolism, and DNA- or 
RNA-binding proteins.
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et al., 2014), and knockdown or knockout of Fus in the mouse brain 
results in gene expression dysregulation (Ishigaki et al., 2012; 
Lagier-Tourenne et al., 2012; Scekic-Zahirovic et al., 2016). Fur-
thermore, AT-hook proteins are often involved in gene expression 
regulation either as transcription factors or as chromatin archi-
tectural proteins (Reeves, 2010), and our results thus far indicate 
that Xrp1 is a nuclear chromatin-binding protein likely involved in 
gene expression regulation. We therefore hypothesized that loss of 
caz function may result in gene expression dysregulation, which 
could possibly be mitigated by heterozygosity for Xrp1.
To test this hypothesis, we used RNA sequencing (RNA-seq) 
to evaluate mRNA expression levels in third instar larval CNS 
of cazKO and cazKO Xrp1 heterozygous animals as well as Xrp1 
heterozygous and WT animals as controls. Principal component 
analysis and clustering of the samples discriminated the four 
genotypes from each other, with a certain degree of overlap 
between Xrp1 heterozygous and WT samples (Fig. S5, A and B). 
Differential gene expression analysis between mRNA levels from 
WT and cazKO identified 1,641 up-regulated and 1,605 down-reg-
ulated genes in caz mutants (FRD-adjusted P value <0.05; Fig. 7, 
A and D; and Table S5), indicating substantial gene expression 
dysregulation. Gene expression changes for caz and Xrp1 were 
consistent with the previously obtained qPCR data (Fig. S5 C). In 
contrast, comparison between WT and Xrp1 heterozygotes iden-
tified only 184 up-regulated and 30 down-regulated genes (Fig. 7, 
B and D). Most interestingly, in caz mutant Xrp1 heterozygous 
CNS, 315 up-regulated and 314 down-regulated genes were iden-
tified, with >90% of these displaying a less than twofold change 
(Fig. 7, C and D). Thus, heterozygosity for Xrp1 significantly mit-
igated gene expression dysregulation in caz mutant CNS. Princi-
pal component analysis confirmed the dramatic gene expression 
dysregulation in caz mutant CNS, which was significantly res-
cued in caz mutant Xrp1 heterozygous animals (Fig. S5 A).
Up- or down-regulation of a panel of 19 genes was validated 
by qPCR (Fig. S5 E), and gene ontology (GO) analysis showed that 
transcripts whose expression was altered in caz mutant animals 
were enriched for genes involved in processes such as axon and 
dendrite guidance, peripheral nervous system development, 
regulation of transcription and mRNA splicing, DNA repair, and 
mitotic spindle organization and assembly (Fig. 7 E). GO analy-
sis for molecular function revealed that transcripts with altered 
expression in caz mutants were enriched for mRNAs encoding 
DNA- and chromatin-binding proteins as well as mRBPs, along 
with transcription factor activity, among others (Fig. S5 D). 
Overall, this is in line with the known functions of Caz and its 
mammalian FET protein orthologues (Schwartz et al., 2015) and 
strikingly similar to results from RNA-seq experiments in Fus−/− 
mice (Scekic-Zahirovic et al., 2016). In conclusion, our transcrip-
tome analysis revealed that gene expression dysregulation in caz 
mutant CNS is substantially mitigated by Xrp1 heterozygosity.
Phenotypes induced by motor neuron–selective 
expression of ALS mutant FUS are substantially mitigated 
by Xrp1 knockdown
To evaluate the potential relevance of our findings for human 
ALS, we used a Drosophila ALS-FUS model. Selective expression 
of R518K mutant human FUS in motor neurons (D42-GAL4) 
yielded adult flies that developed progressive motor deficits 
and displayed a substantially shortened life span (Fig. 8, A–D). 
We therefore evaluated the effect of Xrp1 knockdown on motor 
behavior and life span of these flies. Coexpression of Xrp1-RNAi 
more than tripled the median life span of both male and female 
D42-GAL4>UAS-FUS-R518K flies (Fig. 8, A and B). At 10 d of age, 
FUS-R518K flies displayed a mild climbing defect (reduction in 
speed by ∼12%), which was fully rescued by motor neuron–se-
lective Xrp1 knockdown (Fig. 8 C). At 16 d of age, FUS-R518K flies 
Figure 6.  Functionality of the AT-hook 
DNA-binding domain of Xrp1 is required to 
mediate caz mutant phenotypes. (A) Sche-
matic representation of the Xrp1 transgene in 
the pUAST transgenesis vector, with five UAS 
GAL4-binding sites, and the pJFRC4 vector, with 
three UAS sites. (B) The Xrp1 AT-hook motif con-
sists of nine amino acids including the invariant 
GRP triplet (top). To inactivate the DNA-binding 
capacity of the AT-hook motif, three amino acids 
essential for DNA binding (RGR) were mutagen-
ized to alanine (bottom). (C) Panneuronal expres-
sion (elav-GAL4) of WT or AT-hook mutant (Mut) 
3×UAS-Xrp1 transgenes (short isoform) does 
not induce developmental lethality. Adult off-
spring frequency relative to a driver-only con-
trol (100%) is shown. n > 376 per genotype. (D 
and E) Adult offspring frequency of caz2, elav-
GAL4/Y;; Df(3R)Xrp1Plus/+ (D) or cazKO, elav-
GAL4/Y;; Df(3R)Xrp1Plus/+ (E) males expressing 
3×UAS-Xrp1 transgenes (WT or AT-hook mutant) 
or no transgene (control). n > 115 per genotype. 
***, P < 0.0001; χ2 test.
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displayed a severe climbing defect (reduction in speed by ∼45%), 
which was rescued by knockdown of Xrp1 to a level that was not 
significantly different from D42-GAL4>UAS-Xrp1-RNAi control 
flies (Fig. 8 D). Thus, reduction of Xrp1 levels in motor neurons 
substantially rescues the motor deficits and shortened life span 
of a Drosophila ALS-FUS model.
To gain insight into the mechanism underlying this major phe-
notypic rescue, we evaluated the effect of FUS-R518K overexpres-
sion on caz and Xrp1 transcript levels. Ubiquitous overexpression 
of FUS-R518K in adult female flies moderately reduced caz tran-
script levels to ∼60% of control levels (Fig. 8 E). Strikingly, Xrp1 
transcript levels were about threefold increased upon FUS-R518K 
expression (Fig. 8 F). This substantial increase in Xrp1 expression 
cannot be attributed to the moderate reduction in caz levels be-
cause Xrp1 transcript levels were not altered in caz heterozygous 
females in spite of a ∼50% reduction of caz transcript levels (Fig. 8, 
G and H). Thus, expression of ALS mutant FUS results in substan-
tial up-regulation of Xrp1 expression independent of caz levels. 
The fact that Xrp1 knockdown substantially rescues phenotypes 
induced by ALS mutant human FUS indicates that these pheno-
types are to a large extent mediated by increased Xrp1 expression.
Discussion
In this study, we identified Xrp1 as a genetic modifier of caz 
mutant phenotypes. Caz is the single Drosophila orthologue of 
the three human FET family proteins FUS, EWSR1, and TAF15 
(Schwartz et al., 2015). Xrp1 expression was up-regulated by 
three- to fourfold in caz mutant animals, and heterozygosity for 
Xrp1 fully rescued the caz mutant eclosion defect and partially 
but substantially rescued adult motor performance and life span. 
Exhaustive genetic screening of the second and third chromo-
some, which together constitute ∼80% of the fly genome, iden-
tified Xrp1 as the only gene for which reduction of gene dosage 
by 50% could rescue caz mutant pupal lethality, indicating that 
Xrp1 is a key modifier of caz mutant phenotypes. Interestingly, 
in spite of the previously reported ubiquitous expression of Xrp1 
(Tsurui-Nishimura et al., 2013) and the fact that Xrp1 expres-
sion was not only increased in the CNS but also in the body wall 
and presumably other tissues of caz mutants, neuron-selective 
knockdown of Xrp1 was sufficient to rescue caz mutant pheno-
types, and selective neuronal overexpression of Xrp1 in other-
wise WT animals phenocopied caz mutant phenotypes. This is 
consistent with the previously reported key function of Caz in 
Figure 7.  Heterozygosity for Xrp1 mitigates gene expression dysregulation in caz mutant CNS. (A–C) MA plots displaying gene expression changes 
in cazKO versus w1118 (genetic background control; A), Df(3R)Xrp1Plus/+ versus w1118 (B), and cazKO;; Df(3R)Xrp1Plus/+ versus w1118 (C). X axes represent the 
mean of the normalized read counts per gene across all samples included in each comparison. Y axes represent the log2 fold change per gene resulting from 
each comparison. Green dots correspond with differentially expressed genes, with P < 0.05 adjusted for multiple testing. (D) Venn diagram representing the 
overlap between differentially expressed genes across the three comparisons. Numbers in parenthesis indicate the total number of differentially expressed 
genes in each comparison. (E) Top 10 enriched GO terms (Biological Process ontology) in the cazKO versus w1118 comparison for the set of up-regulated (red) 
and down-regulated genes (blue).
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neurons (Wang et al., 2011; Frickenhaus et al., 2015). Together, 
our data indicate that caz mutant phenotypes are largely medi-
ated by increased Xrp1 expression, with particularly deleterious 
effects in neurons (Fig. 9).
Xrp1 has previously been implicated in protection against 
genotoxic stress and DNA damage repair (Brodsky et al., 2004; 
Akdemir et al., 2007; Francis et al., 2016). Consistently, a num-
ber of Xrp1-interacting proteins are involved in DNA repair 
(Fig. 5 C), and GO analysis of our RNA-seq data revealed enrich-
ment for genes involved in DNA repair among genes up-regulated 
in caz mutant CNS (Fig. 7 E). This study revealed a novel role for 
Xrp1 in gene expression regulation as a substantial number of 
Xrp1-interacting proteins are involved in regulation of transcrip-
tion, chromatin organization, and RNA metabolism (Fig. 5 C). 
Interestingly, neuronal overexpression of the long Xrp1 isoform 
induced significantly stronger phenotypes as compared with the 
short isoform (Fig. 3, G–I; and Fig. S4, D–F), despite insertion of 
the transgenes in the same genomic site and similar expression 
levels (Fig. 3 B). This is likely attributable to the additional N-ter-
minal 262 aa of the long isoform, allowing the binding of sub-
stantially more interacting proteins (Fig. 5 B and Table S2), which 
may result in more pronounced gene expression dysregulation 
and stronger phenotypes.
Consistent with a key role of Xrp1 in gene expression regu-
lation, significant gene expression dysregulation was found in 
caz mutant CNS, which was substantially mitigated by normal-
izing Xrp1 levels in caz mutants (Fig. 7). Importantly, of the 3,246 
differentially expressed genes in caz mutants, only 489 are still 
significantly up- or down-regulated caz mutant Xrp1 heterozy-
gotes (Fig. 7 D). The 2,757 genes that are significantly changed in 
caz mutants but not in caz mutant Xrp1 heterozygotes are likely 
direct or indirect targets of Xrp1, and up- or down-regulation 
Figure 8.  Motor neuron–selective Xrp1 
knockdown mitigates motor deficits and 
shortened life span induced by ALS mutant 
FUS expression. (A and B) Life span of control 
(driver only) flies and flies with motor neuron–
selective (D42-GAL4) expression of human FUS-
R518K, Xrp1-RNAi, or both transgenes. Data for 
male (A) and female (B) flies are shown. n > 75 
per genotype. (C and D) Average climbing speed 
of adult female flies with motor neuron–selective 
(D42-GAL4) expression of human FUS-R518K, 
Xrp1-RNAi, or both transgenes versus driver-only 
controls. Flies were tested at 10 (C) and 16 (D) 
d of age. n > 100 per genotype. **, P < 0.01; 
***, P < 0.005; Mann-Whitney test. (E and F) 
Transcript levels of caz (E) and Xrp1 (F) in heads 
of adult female flies 3 d after induction of ubiq-
uitous FUS-R518K expression (tub-GAL4) versus 
driver-only controls. n = 9–11. ***, P < 0.0005; 
two-tailed unpaired t test. (G and H) Caz (G) and 
Xrp1 (H) transcript levels in the CNS of third instar 
female larvae heterozygous for caz2 or cazKO ver-
sus WT controls. n = 11–13. ***, P < 0.001; one-
way ANO VA. All graphs display mean ± SEM.
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of these genes in caz mutants may contribute to neuronal dys-
function. The novel function of Xrp1 in gene expression regu-
lation is likely dependent on the capacity of Xrp1 to bind DNA, 
presumably mediated by two predicted DNA-binding domains in 
its C terminus: an AT-hook motif and a bZIP motif. Whereas the 
functionality of the predicted bZIP motif remains to be investi-
gated, the AT-hook motif of Xrp1 conforms with the consensus 
sequence, consisting of nine amino acids centered on the in-
variant tripeptide glycine-arginine-proline (Reeves, 2010). The 
DNA-binding capacity of the Xrp1 AT-hook motif is likely re-
quired to mediate gene expression regulation and dysregulation, 
as the introduction of a subtle mutation in this motif demon-
strated that its functionality is essential to mediate caz mutant 
phenotypes. Based on our findings, we propose a working model 
in which caz mutant phenotypes are mediated by increased Xrp1 
expression, leading to gene expression dysregulation and neuro-
nal dysfunction (Fig. 9).
Extensive bioinformatic searches did not reveal a clear one-
to-one Xrp1 orthologue in mammals. However, we believe that it 
is highly likely that Xrp1 has functional homologues in mammals. 
Candidate functional homologues include 27 human genes en-
coding proteins predicted to contain at least one AT-hook motif 
(Table S6), including the Rett syndrome gene MECP2 (Amir et 
al., 1999). Interestingly, DNA binding mediated by the MeCp2 
AT-hook domains has been implicated in the pathogenesis of 
Rett syndrome (Baker et al., 2013), and FUS was reported to bind 
the MECP2 promotor and positively regulate MECP2 transcrip-
tion (Tan et al., 2012). In addition, FUS also binds MECP2 mRNA 
(Lagier-Tourenne et al., 2012), indicating that MECP2 is both a 
transcriptional and mRNA target of FUS. Furthermore, brains 
from Fus−/− mice or transgenic mice overexpressing ALS mutant 
FUS display up-regulation of Cbx2, Dot1l, Elf3, Prr12, and KMT2B 
(Scekic-Zahirovic et al., 2016; Shiihashi et al., 2016), and 17 of the 
27 AT-hook genes are reported FUS RNA targets (Table S6). En 
route toward identification of human functional homologues of 
Xrp1, it will be particularly important to gain detailed molecu-
lar insight into how Xrp1 regulates gene expression. A first step 
could be the identification of the genomic binding sites of Xrp1 
and its putative target genes. Furthermore, since Xrp1 does not 
have other predicted functional domains apart from the AT-hook 
Figure 9.  Xrp1 is a key mediator of caz 
mutant phenotypes. (A) In WT animals, Caz 
controls Xrp1 levels, resulting in normal gene 
expression regulation. (B) Loss of caz function 
results in substantial up-regulation of Xrp1 
expression, leading to gene expression dysreg-
ulation and neuronal dysfunction. (C) In caz 
mutant Xrp1 heterozygous animals, Xrp1 lev-
els are normalized, resulting in rescue of gene 
expression dysregulation and neuronal dys-
function. (D) Expression of ALS mutant human 
FUS results in substantial up-regulation of Xrp1 
expression, and motor neuron–selective expres-
sion induces neuronal dysfunction and reduced 
life span. (E) Simultaneous knockdown of Xrp1 
in motor neurons expressing FUS-R518K rescues 
neuronal dysfunction and reduced life span.
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and bZIP domains, it is tempting to speculate that Xrp1 regulates 
gene expression by recruiting other proteins that contain func-
tional domains such as transactivation or histone-modifying 
domains to specific genomic sites. Several of the Xrp1-interact-
ing proteins identified in this study contain such functional do-
mains and have human orthologues (e.g., TAF9, ZMYM2, NFX1, 
HCFC1/2, VRK1, RSF1, and BPTF).
Interestingly, gene expression dysregulation was previously 
implicated in ALS and FTD pathogenesis. For instance, a signif-
icant enrichment in de novo mutations in the chromatin regu-
latory pathway in sporadic ALS patients was reported (Chesi et 
al., 2013). Furthermore, involvement of the three FET proteins in 
regulation of transcription and mRNA splicing is well established 
(Schwartz et al., 2015), and in fact, several other RBPs that have 
been implicated in ALS and FTD pathogenesis are also known to 
play important roles in gene expression regulation (Ling et al., 
2013). These include TDP-43, involved in regulation of transcrip-
tion and mRNA splicing (Buratti and Baralle, 2010), which mislo-
calizes to cytoplasmic inclusions with nuclear clearance in >95% 
of ALS and ∼45% of FTD patients (Ling et al., 2013). Furthermore, 
the ALS-causing expanded hexanucleotide repeat in C9orf72 may 
sequester RBPs, thus inducing gene expression dysregulation 
(Lee et al., 2013; Haeusler et al., 2014). The potential relevance 
of our findings for ALS-FUS pathogenesis is further indicated by 
the fact that knockdown of Xrp1 substantially rescues the motor 
deficits and shortened life span of flies that selectively express 
ALS mutant human FUS in motor neurons (Figs. 8 and 9). This 
may be explained by a substantial increase in Xrp1 expression 
induced by mutant FUS, which is not attributable to the moderate 
(∼40%) down-regulation of caz expression.
Finally, our findings may also be relevant for FTLD-FUS patho-
genesis as this disease is characterized by pathological inclusions 
containing not only FUS but also TAF15 and EWS, with reduced 
levels or complete loss of nuclear FET proteins in inclusion-bear-
ing neurons and glial cells (Neumann et al., 2011; Davidson et al., 
2013). Thus, loss of FET protein function and consequent gene 
expression dysregulation may contribute to FTLD-FUS patho-
genesis. Consistently, FUS knockout or knockdown in the hip-
pocampus of mice induces behavioral aberrations related to FTD 
symptoms (Kino et al., 2015; Udagawa et al., 2015). In conclusion, 
our findings provide important novel insights into the molecu-
lar mechanisms by which loss of Caz, the Drosophila orthologue 
of human FET proteins, induces motor deficits and reduced life 
span, and they suggest that gene expression dysregulation may 
be involved in the pathogenesis of human FUSopathies.
Materials and methods
Drosophila genetics
Flies were housed in a temperature-controlled incubator with 
12:12 h on/off light cycle at 25°C, and for some experiments, at 
23°C (5×UAS-Xrp1 overexpression), in vials containing standard 
cornmeal medium. X chromosome–inserted elav-GAL4 (458; 
Bloomington Drosophila Stock Center [BDSC]) was used for pan-
neuronal expression of UAS transgenes, OK371-GAL4 and D42-
GAL4 were used for targeted expression in motor neurons, and 
tub-GAL4 was used for ubiquitous expression of UAS transgenes.
For the dominant suppressor screen, deficiencies covering 
the second and the third chromosome from the Bloomington 
Deficiency Kit were used as this kit provides maximal coverage 
(euchromatic coverage ≥ 97.5%) with a minimal number of dele-
tions (Cook et al., 2012). Df/Balancer males were crossed to caz2/
FM7 females to screen for the emergence of caz2/Y; Df/+ males 
in the offspring, which would indicate suppression of pupal 
lethality of caz2 males by hemizygosity for the deficiency. To 
narrow down the genomic region that is uncovered by Df(3R)
ED2, the deficiency that mediated rescue of caz mutant pupal 
lethality, molecularly mapped smaller deficiency lines in this 
region were ordered from the BDSC. PCR genotyping of caz mu-
tant males was used to exclude X chromosome nondisjunction 
in all experiments.
The UAS-Xrp1-RNAi lines used in this study were P[TRiP.
HMS00053]attP2 (34521; BDSC; UAS-Xrp1-RNAi-1) and 
P[GD9476]v33010 obtained from the Vienna Drosophila Resource 
Center (UAS-Xrp1-RNAi-2). The UAS-FUS-R518K transgenic line 
was generated by and obtained from Lanson et al. (2011).
Generation of Xrp1 mutant lines
For generation of Xrp1 deletion lines, P[XP]d11439, P[XP]
Xrp1d04790, PBac[WH]f07598, and PBac[WH]f05721 were ob-
tained from the Drosophila Genetic Resource Center at the 
Kyoto Institute of Technology and used to isolate Xrp1 chromo-
somal deletions (Fig.  1, D and E) following the basic schemes 
outlined by Parks et al. (2004). The chromosomal deletions 
generated were verified by PCR with primers flanking the trans-
posable element insertions (Table S7), followed by sequencing of 
the PCR fragments.
For generation of a clean Xrp1-null allele, in vivo homologous 
recombination was used to target the Xrp1 gene. Following a 
previously published strategy (Vilain et al., 2014), the presence 
of a Mi{MIC} transposon in the Xrp1 gene (Mi{MIC}Xrp1MI07118) 
was exploited for site-specific insertion of a targeting construct 
(Figs. 1 and S1 C). For the construction of a targeting vector, a 
fosmid (FlyFos clone number FF017187) containing the extended 
Xrp1 genomic region was used to PCR amplify left and right ho-
mology arms using the primers Xrp1_LHA_FW, Xrp1_LHA_REV, 
Xrp1_RHA_FW, and Xrp1_RHA_REV (Table S7). To minimize the 
chance of introducing mutations during PCR amplification, Phu-
sion high-fidelity DNA polymerase (New England Biolabs) was 
used with only 20 cycles of PCR amplification. The obtained PCR 
products were subcloned in a Zero Blunt TOPO PCR cloning vec-
tor (Invitrogen) and sequence verified. The presence of a HindIII 
site in primer Xrp1_LHA_FW and an EcoRI site in primer Xrp1_
LHA_REV was subsequently used to clone the left homology arm 
into pABC (Choi et al., 2009). Next, the presence of an EcoRI site 
in Xrp1_RHA_FW and a KpnI site in Xrp1_RHA_REV was used to 
clone the right homology arm into the pABC vector that already 
contained the left homology arm.
The obtained targeting vector was sequence verified and in-
jected into Mi{MIC}Xrp1MI07118 embryos for site-specific integra-
tion of the targeting construct into the Mi{MIC} transposable 
element in the Xrp1 gene. Transgenic lines in which the trans-
genic construct was integrated into Mi{MIC}Xrp1MI07118 in the cor-
rect orientation were identified. These lines were subsequently 
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crossed to a transgenic line that expresses I-SceI under the con-
trol of a heat-inducible promoter. Given the presence of an I-SceI 
restriction site in primer Xrp1_LHA_FW, this will induce a dou-
ble-strand break adjacent to the left homology arm of the targeting 
construct, allowing for precise removal of the Xrp1 and Mi{MIC} 
sequences left of the targeting construct through homologous re-
combination (Fig. S1 C). Lines with successful homologous recom-
bination were identified by PCR and sequencing of the obtained 
PCR fragments. Next, these lines were crossed to a transgenic line 
that expresses I-CreI under the control of a heat-inducible pro-
motor. Given the presence of an I-CreI restriction site in primer 
Xrp1_RHA_REV, this will induce a double-strand break adjacent 
to the right homology arm of the targeting construct, allowing for 
precise removal of the Xrp1 and Mi{MIC} sequences right of the 
targeting construct through homologous recombination. Lines 
with successful homologous recombination were identified by 
PCR and sequencing of the obtained PCR fragments.
Generation of UAS-Xrp1 transgenic lines
For generation of UAS-Xrp1Long transgenic lines, RNA was ex-
tracted from WT flies and converted into cDNA, which was used 
as a template for PCR (primer sequences in Table S7) to am-
plify the transcript coding for the long Xrp1 isoform. Gold clone 
FI10013 containing the Xrp1Short cDNA was obtained from Kyoto 
Stock Center. Xrp1Long and Xrp1Short cDNAs were subsequently 
cloned into pUAST-attB using either NotI or EagI as well as XhoI 
restriction sites (Table S7). Site-directed PCR mutagenesis was 
used to generate AT-hook mutant versions of the long and short 
Xrp1 isoforms (mutagenesis primers are included in Table S7). 
WT and AT-hook mutant Xrp1 cDNAs were subsequently ampli-
fied by PCR using Phusion high-fidelity DNA polymerase (New 
England Biolabs) and primers containing XhoI and XbaI restric-
tion sites (Table S7). The obtained PCR products were subcloned 
in a Zero Blunt TOPO PCR cloning vector (Invitrogen), and XhoI 
and XbaI were used to transfer the Xrp1 cDNAs to the pJFRC4 vec-
tor, which contains three UAS sites (Pfeiffer et al., 2010). UAS 
constructs were embryo injected following standard procedures. 
For each of the constructs, VK31 (on III) and VK37 (on II) genomic 
landing sites were used to avoid any influence of neighboring 
genomic sequences on transgene expression. As neuronal ex-
pression of 5×UAS-Xrp1 transgenes (elav-GAL4) in many cases 
resulted in developmental lethality with no adult escapers when 
raised at 25°C, experiments in which elav-GAL4 was used to drive 
expression of 5×UAS-Xrp1 transgenes were performed at 23°C.
Motor performance assay
For assaying mobility, flies were collected within 24  h after 
eclosion and divided into groups of 10 individuals. Motor per-
formance of 3-, 10-, or 16-d-old flies was evaluated as described 
earlier (Frickenhaus et al., 2015; Niehues et al., 2015), and av-
erage climbing speed (mm/s) was determined and compared 
between genotypes. As female D42-GAL4>FUS-R518K flies lived 
longer than males, we studied the effect of Xrp1 knockdown on 
age-dependent motor deficits in female flies.
Larval locomotion was analyzed using the frustrated total in-
ternal reflection–based imaging method FIM (Risse et al., 2013, 
2014, 2017). Batches of 15 third instar larvae were allowed to 
freely move for 3 min on a recording platform at RT. Tracking 
data were obtained using FIMTrack (http:// fim .uni -muenster 
.de), and output files were analyzed with MatLab (MathWorks). 
In Fig. S3 B, larvae were sorted in a Petri dish with water for ∼5 
min, and only male larvae were recorded.
Adult offspring frequency and life span analysis
For determination of adult offspring frequencies, appropriate 
crosses were set up, and the number of adult flies eclosing was 
counted for each genotype. For life span analysis, newly eclosed 
flies were collected and housed at a density of 10 flies per vial. At 
least 75–100 flies were tested for each genotype. The number of 
dead flies was counted every day, and the flies were transferred 
to fresh food vials every 2–3 d.
Real-time qPCR
Total RNA was extracted from 15–20 third instar larval brains or 
from four adult male flies per biological replicate using Nucle-
oSpin RNA (Macherey-Nagel) according to the manufacturer’s 
instructions. Reverse transcription was performed on 1 µg RNA 
treated with gDNA Wipeout Buffer using the Quantitect Reverse 
Transcription kit (QIA GEN). Resulting cDNA samples were used 
as templates for real-time PCR assays performed on an ABI 7300 
system (Applied Biosystems) with iTaq Universal SYBR Green 
supermix (Bio-Rad Laboratories). Primers used for quantitation 
of caz and Xrp1 transcript levels are listed in Table S7. Measure-
ments were normalized to EifTuM and rp49 controls. Data were 
analyzed using the ΔΔCt calculation method. Experiments in-
cluded no–reverse transcriptase controls for each template and 
no-template controls for each pair of primers.
Western blotting
For Western blots, protein extracts were made by homogenizing 
third instar larval CNS in extraction buffer (50 mM Tris/HCl, pH 
7.4, 150 mM KCl, 0.25 M sucrose, 5 mM MgCl2, and 0.5% Triton 
X-100). Lysates of Drosophila S2 cells transfected with plasmids 
encoding actin5C-GAL4 alone or cotransfected with plasmids en-
coding N-terminal HA-tagged Xrp1Short or Xrp1Long were prepared 
in cell lysis buffer (20 mM Tris, 200 mM NaCl, 1 mM EDTA, and 
0.5% NP-40 containing 1 U complete mini protease inhibitor cock-
tail [Roche]). Samples separated on 10% SDS-PAGE were electro-
transferred onto polyvinylidene difluoride (EMD Millipore) for 45 
min at 15 V. Blotted membranes were incubated overnight at 4°C 
with primary antibodies against Caz (mouse monoclonal 3F4; 1:30; 
Immanuel et al., 1995), HA epitope tag (mouse monoclonal HA.11; 
1:1,000; Covance), and β-tubulin (mouse monoclonal E7; 1:700; De-
velopmental Studies Hybridoma Bank). Immunoreactive proteins 
were visualized after incubation with anti-mouse IgG coupled to 
horseradish peroxidase (W402B; 1:2,500; Promega) for 1 h at RT. 
Blots were developed with enhanced chemiluminescence (GE 
Healthcare), and x-ray film images of chemiluminescence were 
developed and scanned. Densitometric quantification of images 
was performed with ImageJ/FIJI (National Institutes of Health).
Coimmunoprecipitation
For detection of potential homodimers of Xrp1Short and Xrp1Long, 
Drosophila S2 cells were either transfected with a plasmid encod-
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ing actin5C-GAL4 alone or cotransfected with plasmids encoding 
N-terminal HA- or Flag-tagged Xrp1Short or Xrp1Long constructs, all 
under UAS control. 48 h after transfection, protein lysates of cells 
expressing HA- or Flag-tagged Xrp1 were either directly used or 
combined in a 1:1 ratio. 5% of protein extracts were used for West-
ern blotting, while the remaining 95% were added to anti-HA 
agarose beads for 24 h at 4°C. Immunoprecipitation of HA-tagged 
proteins was performed using an Anti-HA Immunoprecipitation 
Kit (Sigma-Aldrich), according to the manufacturer’s protocol.
To evaluate whether Caz and Xrp1 physically associate with 
each other, S2 cells expressing the actin5C-GAL4 plasmid alone 
(control) or in conjunction with the N-terminal HA-tagged 
Xrp1Short or Xrp1Long constructs were seeded at a density of 106 
cells/ml in 1 ml Shields and Sang medium (Sigma-Aldrich) in 12-
well plates 1 d before transfection. Transfection was performed 
using Fugene HD Transfection Reagent (Promega) according to 
manufacturer’s instructions. Cell lysates were prepared, cellular 
debris was pelleted by centrifugation at 12,000 g for 15 min and 
washed, and the protein-containing supernatant was incubated 
overnight at 4°C with 100 µl of either anti-Flag (10 µg; clone M2; 
F1804; Sigma-Aldrich) or anti-Caz (10 µg; 3F4; Immanuel et al., 
1995) conjugated SureBeads Protein G Magnetic Beads (Bio-Rad 
Laboratories) according to the manufacturer’s instructions. 
Bound proteins were eluted by heating to 70°C for 10 min with 
40 µl of 1× Laemmli buffer (Bio-Rad Laboratories).
Inputs, precipitates, and binding proteins were analyzed by 
SDS-PAGE and immunoblotting. The immunoblot analyses were 
performed using the following primary antibodies: anti-Flag 
(clone M2; F1804; 1:1,500; Sigma-Aldrich) and anti-HA (Mono 
HA.11; 1:1,000; Covance).
Liquid chromatography (LC)–tandem MS analysis
S2 cells were seeded at a density of 106 cells/ml in 3 ml Shields 
and Sang medium (Sigma-Aldrich) in six-well plates 1 d before 
transfection. Flag-tagged Xrp1Short or Xrp1Long plasmids were 
transfected, along with the actin5C-GAL4 construct. Three rep-
licates were processed for each condition. After incubating the 
cells for 2 d with the transfection mixes, cells were collected and 
lysed in cell lysis buffer (described above). Cellular debris was 
cleared by centrifugation at 12,000 g for 15 min. To pull down 
Xrp1-interacting proteins, the protein-containing supernatant 
was applied to 100  µl anti-Flag (clone M2; F1804; Sigma Al-
drich)–conjugated SureBeads Protein G Magnetic Beads (Bio-Rad 
Laboratories) according to the manufacturer’s instructions. Cell 
lysates were incubated with the antibody beads overnight at 4°C. 
Washed beads were resuspended in 4% SDS and 50 mM Tris, pH 
7.5, and bound proteins were eluted by heating to 95°C for 10 min 
and then precipitated with a fourfold excess (vol/vol) of ice-cold 
acetone overnight to remove detergent and salts. Precipitated 
protein pellets were washed twice with 90% acetone, air dried, 
and then resuspended in 8 M urea and 50 mM Tris-HCl, pH 8.5, 
before in-solution digestion, first with endopeptidase LysC (1 µg/
immunoprecipitation) for 3 h at 37°C, and then with trypsin over-
night at 37°C (1.5 µg/immunoprecipitation). After acidification 
of the digest by addition of 1% formic acid (final concentration), 
peptides were desalted using Empore-C18 StageTips (Rappsilber 
et al., 2003) and stored at 4°C until further use. Prior to LC–tan-
dem MS, peptides were eluted using 2 × 20 µl of 80% acetonitrile 
and 0.1% formic acid, and then they were dried in an Eppendorf 
concentrator to a volume of ∼2 µl and resuspended in 10 µl buf-
fer A (0.1% acetic acid). 6 µl of this peptide solution was then 
analyzed by nanoscale reverse-phase chromatography using 
an EASY nLC 1200 (Thermo Fisher Scientific) as a high-perfor-
mance LC pump and a Picofrit column (25 cm × 75 µm ID; New 
Objective) filled with C18 reverse-phase material (Reprosil pur 
C18-AQ; 1.9 µm; Dr. Maisch GmbH) that was online coupled via 
a Nanospray Flex electrospray ionization source (Thermo Fisher 
Scientific) to a QExactive HF mass spectrometer (Thermo Fisher 
Scientific). Peptides were separated at a flow rate of 300 nl/min 
using a gradient running from 3–35% B (80% acetonitrile and 
0.1% formic acid) in 90 min, which was ramped up to 100% B 
in 5 min, where it was maintained for additional 10 min before 
reequilibration at starting conditions. Column temperature was 
maintained at 45°C with the help of a column oven (PRSO-V1; 
Sonation). The mass spectrometer was operated in data-depen-
dent mode, acquiring full-scan spectra in profile mode at a res-
olution of 60,000 and an automatic gain control target value of 
3 × 10−6 (scan range 300–1,650 m/z). Spray voltage was set to 2.1 
kV. The 17 most intense ions were chosen for higher energy col-
lisional dissociation with a resolution of 15,000 at m/z 200 and 
a target value of 10−5. The isolation window was set to 1.6 m/z, 
and the normalized collision energy to a value of 28. Dynamic 
exclusion was allowed and set to 20 s. Uncharged as well as singly 
charged compounds were excluded from the analysis as well as 
peptides with a charge state >6. Data were recorded with Xcalibur 
software (Thermo Fisher Scientific).
MS data analysis
Raw MS files were processed using the MaxQuant computa-
tional platform (version 1.5.3.8; Cox and Mann, 2008). The An-
dromeda search engine integrated into MaxQuant was used for 
the identification of peptides and proteins by querying a con-
catenated forward and reverse UniProt Drosophila database 
(UP000000803_7227.fasta; release 2015-12), including common 
laboratory contaminants. The search for precursor and fragment 
ions was performed allowing an initial mass deviation of 20 ppm 
and 0.5 D, respectively. Trypsin with full enzyme specificity was 
selected, and only peptides with a minimum length of seven 
amino acids were allowed. A maximum of two missed cleavages 
was allowed. Carbamidomethylation (Cys) was set as fixed mod-
ification, while oxidation (Met) and N-acetylation were defined 
as variable modifications. For protein and peptide identification, 
a minimum false discovery rate of 1% was required. Label-free 
quantification (LFQ) was based on the measurements of three 
independent biological replicates for each strain analyzed by 
the MaxQuant LFQ algorithm with the “match between runs” 
option turned on (Cox et al., 2014). Further data processing was 
performed using the bioinformatics module Perseus (version 
1.5.6.0; Cox et al., 2011). Following initial filtering and grouping 
(actin; caz; XRP1-L; XRP1-s), LFQ values were log2 transformed, 
and only proteins were included in the analysis that were iden-
tified with at least three valid values in at least one of the four 
groups. Still-missing values (NaN) were replaced by imputation, 
simulating signals of low abundant proteins within the distri-
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bution of measured values. A width of 0.3 SD and a downshift 
of 1.8 SD were used for this purpose. To identify proteins that 
displayed significant differences between the groups, ANO VA 
testing was performed (P = 0.05). Fold enrichment was calculated 
based on LFQ intensity values. The MS proteomics data have been 
deposited to the public PRI DE repository (Vizcaíno et al., 2013) 
via the ProteomeXchange platform (http:// proteomecentral 
.proteomexchange .org) with the dataset identifier PXD008417.
Immunocytochemistry and histochemistry
Drosophila S2R+ cells were seeded in a density of 4 × 105 cells/ml 
on Concanavalin A (Sigma-Aldrich)–treated circular microscope 
cover glasses (12 mm; VWR) in a 24-well cell culture dish. After 
24 h at 25°C, cells were transfected with a mix containing the 
Fugene HD transfection reagent (Promega) and actin5C-GAL4 
and UAS-HA::Xrp1Short plasmids. 48 h later, cells were fixed in 4% 
PFA for 15 min followed by two 5-min washes in DPBS (1×; Gibco) 
at RT. After permeabilization with DPBS (1×) and 0.5% Triton X-
100, cells were washed twice with DPBS. Cells were blocked for 
1 h in 2% BSA and 10% goat serum in DPBS, followed by overnight 
incubation at 4°C with primary antibodies against Caz (mouse 
monoclonal clone 3F4; 1:30; Immanuel et al., 1995), lamin (mouse 
monoclonal ADL67.10; 1:100; Developmental Studies Hybridoma 
Bank), and HA (rabbit polyclonal; 1:50; Santa Cruz Biotechnol-
ogy) diluted in 2% BSA and 10% goat serum in DPBS. After two 
washes in DPBS, secondary goat anti-mouse and anti-rabbit anti-
bodies (Alexa Fluor 488 and 568; 1:500) were applied for 2 h at RT, 
followed by three washes in DPBS and mounting on microscopy 
slide with Aqua-Poly/Mount (Polysciences, Inc.).
For subcellular localization of Xrp1 in motor neurons, brains/
CNS from wandering third instar larvae expressing OK371-
GAL4>UAS-mCD8::GFP alone (control) or in conjunction with 
UAS-Xrp1Short were dissected in PBS and fixed in 4% PFA for 30 
min. Tissues were washed 3 × 10 min in PBS/0.2% Triton X-100 
and blocked for 1 h at RT in 10% goat serum in PBS. Tissues were 
incubated with primary antibodies against Caz (mouse mono-
clonal clone 3F4; 1:30; Immanuel et al., 1995), lamin (mouse 
monoclonal ADL67.10; 1:100; Developmental Studies Hybridoma 
Bank), or HA (rabbit polyclonal; 1:50; Santa Cruz Biotechnology) 
overnight at 4°C with gentle agitation. Appropriate secondary 
antibodies conjugated either with Alexa Fluor 405, Alexa Fluor 
488, or Alexa Fluor 568 (Molecular Probes) were used to detect 
the given primary antibody. All images were acquired using 
ZEN 2010 software on a Zeiss LSM700 laser scanning confo-
cal microscope using an EC Plan neofluar 1.3 NA 40× oil-im-
mersion objective.
Squash preparation of polytene chromosomes from larval 
salivary glands
For preparing polytene chromosome squashes, salivary glands of 
WT third instar larvae were dissected in PBS (1×) and transferred 
to 1% Triton X-100 for 30 s. Fixation was in 4% PFA (1 min) and in 
45% acetic acid/4% PFA (2 min). The glands were then incubated 
in 45% acetic acid (1 min) and subsequently squashed in the same 
solution under a coverslip to get polytene spreads. After freezing 
the slides in liquid nitrogen, coverslips were flipped off with a 
sharp blade, and slides were stored in 90% ethanol.
For immunostaining, squash preparations were rehydrated 
twice for 5 min in PBS (1×). Immunostaining was performed follow-
ing the Dangli and Bautz (1983) procedure using rabbit polyclonal 
anti-Xrp1 (1:50; Francis et al., 2016) followed by an Alexa Fluor 
568–conjugated secondary antibody (1:500; Molecular Probes). 
The preparation was counterstained with DAPI and mounted in 
Vectashield antifade mounting medium (Vector Laboratories) for 
confocal microscopy. All images were acquired using ZEN 2010 
software on a Zeiss LSM700 laser scanning confocal microscope 
using an EC Plan neofluar 1.3 NA 40× oil immersion objective.
RNA-seq and data analysis
For RNA-seq, total RNA was extracted from 15–20 brains dissected 
from wandering third instar male larvae using NucleoSpin RNA 
(Macherey-Nagel) according to the manufacturer’s instructions. 
After performing quality control checks, the RNA was sent to the 
Max Planck Genome Center, where cDNA libraries were prepared 
using the NEBNext Ultra Directional RNA Library Prep Kit for Il-
lumina (New England Biolabs) using standard procedures. The 
libraries were sequenced on an Illumina HiSeq 2500 instrument 
as 100-bp paired-end reads each according to the manufactur-
er’s standard protocols. Three biological replicates per genotype 
were sequenced, with an average of 8.6 million nonredundant 
read pairs uniquely mapped to the Drosophila genome.
Preprocessing filtering of the reads before alignment, e.g., 
quality- or adapter-trimming, was not necessary. The Droso- 
phila reference genome was downloaded from Flybase. Revision 
6.04 of the genome assembly and gene annotation was used for 
all analyses. We aligned reads to the reference transcriptome 
using the TopHat pipeline (version 2.0.14; Kim et al., 2013a) 
with Bowtie2 (version 2.2.5; Langmead and Salzberg, 2012) and 
the flags b2-very-sensitive and library-type = fr-firststrand. The 
mapped reads were assigned to genes using the HTseq-count 
script from the HTseq package (Anders et al., 2015). We used 
the intersection-nonempty mode to exclude ambiguous gene 
assignments. Aligned pairs with a mapping quality <10 were 
excluded, and rRNA genes were removed from the gene list for 
further analysis.
Differential gene expression analysis was performed using 
DeSeq2 (version 1.11; Love et al., 2014). All comparisons were 
performed in a pairwise manner, comparing samples of each 
genotype separately against the WT. We chose to disable filtering 
genes based on Cook’s distance for the whole analysis because we 
observed that the high biological variability of Xrp1 heterozygous 
animals lead to the exclusion of a large number of genes. Genes 
were called differentially expressed if the log2 fold change dif-
fered significantly from 0 with a false discovery rate–adjusted P 
value of <0.05. Expression levels for each annotated protein-cod-
ing gene were determined by the number of mapped reads per 
kilobase of exon per million mapped reads (RPKM).
Principal component analysis and hierarchical clustering of 
the global expression profile was performed on a variance-stabi-
lized transformation of the read counts per gene using methods 
provided by the DeSeq2 R-package. For clustering, the distances 
between samples were calculated using the Manhattan distance 
metric. Based on the distance matrix, hierarchical clustering by 
complete linkage was performed using standard R functions.
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GO-term enrichment analysis was done using the topGO 
package for R (version 2.22; Alexa et al., 2006). We extracted the 
sets of up- and down-regulated genes for each comparison from 
the DeSeq2 analysis and used the “weight01” algorithm in topGO 
in combination with Fisher’s exact test to check for enrichment 
of specific GO terms in these gene sets.
Statistical analysis
χ2 statistics were used to analyze offspring frequency data. For 
life span analysis, the log-rank test was used to test for statis-
tical significance. Motor performance was analyzed using the 
Mann-Whitney U test to compare climbing speed of individual 
flies per genotype and per run. As all flies were tested in three 
independent runs, three P values were generated per genotype. 
These P values were combined using the Fisher’s combined prob-
ability test. To analyze larval locomotion data, Mann-Whitney 
rank-sum tests were performed with MatLab. One-way ANO VA 
with Bonferroni correction was used to analyze Caz and Xrp1 
mRNA and protein levels as data displayed normal distribution 
and equal variance. All images were assembled in figure panels 
using the Adobe Illustrator CS5 software.
Online supplemental material
Fig. S1 shows generation and characterization of Xrp1 mutant 
and transgenic lines. Fig. S2 shows that heterozygosity for Xrp1 
does not rescue the adult eclosion defect of TBPH mutant flies. 
Fig. S3 shows larval locomotion phenotypes and binding of WT 
or AT-hook mutant Xrp1 to polytene chromosomes. Figs. S4 
shows characterization of the caz-Xrp1 genetic interaction. Fig. 
S5 shows that heterozygosity for Xrp1 mitigates gene expression 
dysregulation in caz mutant CNS. Table S1 lists human homo-
logues of Xrp1. Tables S2, S3, and S4 list Xrp1long, Xrp1Short, and 
Caz-interacting proteins, respectively. Table S5 lists RNA-seq 
results. Table S6 lists human AT-hook genes. Table S7 lists oligo-
nucleotide primers.
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TABLE S1: HUMAN HOMOLOGS OF XRP1 
Protein ID Protein name E-value with 
XRP1 
XP_005258748.1 protein fosB isoform X1 1.1E-10 
NP_004355.2 CCAAT/enhancer-binding protein alpha isoform a 1.5E-09 
XP_011523007.1 hepatic leukemia factor isoform X2 8.3E-09 
XP_016868299.1 
cyclic AMP-responsive element-binding protein 5 
isoform X5 
0.000000011 
XP_016876460.1 jun dimerization protein 2 isoform X1 0.000000038 
NP_005186.2 CCAAT/enhancer-binding protein delta 0.000000059 
NP_001181986.1 DNA damage-inducible transcript 3 protein isoform 2 0.000000083 
NP_005243.1 proto-oncogene c-Fos 0.00000014 
XP_016881877.1 D site-binding protein isoform X1 0.00000024 
NP_005429.1 fos-related antigen 1 isoform 1 0.00000042 
NP_002117.1 hepatic leukemia factor isoform 1 0.00000057 
NP_001254492.1 cAMP-responsive element modulator isoform 24 0.00000093 
XP_016859226.1 fos-related antigen 2 isoform X3 0.0000013 
NP_004895.2 
cyclic AMP-responsive element-binding protein 5 
isoform beta 
0.0000019 
NP_877962.1 cyclic AMP-dependent transcription factor ATF-4 0.0000023 
NP_001343.2 D site-binding protein   0.0000023 
NP_919047.2 
cyclic AMP-responsive element-binding protein 3-
like protein 2 isoform 1 
0.0000025 
NP_005244.1 fos-related antigen 2 0.0000026 
XP_016883059.1 nuclear factor interleukin-3-regulated protein-like 0.0000037 
NP_002220.1 transcription factor jun-B 0.0000050 
NP_005375.2 nuclear factor interleukin-3-regulated protein 0.0000085 
NP_061134.1 basic leucine zipper transcriptional factor ATF-like 3 0.000012 
XP_016871216.1 cAMP-responsive element modulator isoform X21 0.000012 
NP_612465.3 
basic leucine zipper transcriptional factor ATF-like 2 
isoform 1 
0.000012 
NP_001073007.1 X-box-binding protein 1 isoform XBP1(S) 0.000015 
NP_001025458.1 
cyclic AMP-dependent transcription factor ATF-3 
isoform 1 
0.000020 
XP_005250598.1 
cyclic AMP-responsive element-binding protein 3-
like protein 2 isoform X1 
0.000021 
NP_036200.2 cyclic AMP-dependent transcription factor ATF-5 0.000022 
XP_006718443.1 
cyclic AMP-responsive element-binding protein 3-
like protein 1 isoform X1 
0.000023 
NP_001243019.1 
cyclic AMP-dependent transcription factor ATF-2 
isoform 1 
0.000024 
NP_003207.1 thyrotroph embryonic factor isoform 1 0.000025 
NP_443086.1 
cyclic AMP-responsive element-binding protein 3-
like protein 1 
0.000030 
NP_006390.1 basic leucine zipper transcriptional factor ATF-like 0.000031 
NP_001123532.1 
cyclic AMP-dependent transcription factor ATF-7 
isoform 3 
0.000034 
XP_016878722.1 transcription factor Maf isoform X1 0.000060 
NP_001273897.1 transcription factor jun-D isoform deltaJunD 0.000065 
NP_004372.3 
cyclic AMP-dependent transcription factor ATF-6 
beta isoform a 
0.000078 
XP_016874825.1 
cyclic AMP-dependent transcription factor ATF-1 
isoform X3 
0.000081 
XP_016858890.1 
cyclic AMP-responsive element-binding protein 1 
isoform X8 
0.00015 
NP_002219.1 transcription factor AP-1 0.00016 
NP_002219.1 transcription factor AP-1 0.00016 
NP_005452.2 transcription factor MafB 0.00020 
NP_031374.2 
cyclic AMP-dependent transcription factor ATF-6 
alpha 
0.00025 
NP_874386.1 cAMP-responsive element modulator isoform 4 0.00029 
NP_001177.1 transcription factor BACH1 0.00048 
XP_011521880.1 transcription regulator protein MafG 0.00048 
Human homologs of Xrp1 (E-value < 0.001) ranked according to E-value. Homology detection was done 
with HHpred against the human proteome, using the default settings (three multiple-sequence alignment 
iterations with HHblits). Protein isoforms from the same gene were removed. All homologs are against the C-
terminal, bZIP domain. None of the homologs contains an AT-hook motif. 
 
TABLE S6: HUMAN GENES ENCODING AT-HOOK PROTEINS 
Gene 
name 
Ensembl Gene ID Ensembl Protein 
ID 
Chromosomal 
location 
Upregulated in 
FUS mutant mice 
FUS splice 
target 
FUS RNA 
target 
PMID references 
AHCTF1 ENSG00000153207 ENSP00000355464 Chr 1 q44   Yes 24204307, 22081015 
AHDC1 ENSG00000126705 ENSP00000247087 Chr 1 p36.11     
ASH1L ENSG00000116539 ENSP00000357330 Chr 1 q22   Yes 24204307, 22081015 
ELF3 ENSG00000163435 ENSP00000352673 Chr 1 q32.1 Yes   27368346 
FAM171B ENSG00000144369 ENSP00000304108 Chr 2 q32.1   Yes 22081015, 22427648 
BOD1L1 ENSG00000038219 ENSP00000040738 Chr 4 p15.33     
HMGA1 ENSG00000137309 ENSP00000363230 Chr 6 p21.31   Yes 22081015 
SCML4 ENSG00000146285 ENSP00000358018 Chr 6 q21  Yes  25907258 
ZBTB24 ENSG00000112365 ENSP00000230122 Chr 6 q21     
KMT2C ENSG00000055609 ENSP00000262189 Chr 7 q36.1     
KMT2A ENSG00000118058 ENSP00000436786 Chr 11 q23.3     
PHF21A ENSG00000135365 ENSP00000323152 Chr 11 p11.2   Yes 22081015 
BAZ2A ENSG00000076108 ENSP00000448760 Chr 12 q13.3  Yes Yes 23023293, 22081015 
HMGA2 ENSG00000149948 ENSP00000384026 Chr 12 q14.3   Yes 22081015 
PDS5B ENSG00000083642 ENSP00000313851 Chr 13 q13.1   Yes 24204307, 22081015 
SRCAP ENSG00000080603 ENSP00000262518 Chr 16 p11.2  Yes Yes 25907258, 22081015 
GLYR1 ENSG00000140632 ENSP00000390276 Chr 16 p13.3   Yes 22081015 
CBX2 ENSG00000262762 ENSP00000460115 Chr 17 q25.3 Yes  Yes 23023293, 22081015 
SETBP1 ENSG00000152217 ENSP00000282030 Chr 18 q12.3   Yes 22081015 
DOT1L ENSG00000104885 ENSP00000381657 Chr 19 p13.3 Yes  Yes 
23023293, 24204307, 
22081015 
PRR12 ENSG00000126464 ENSP00000394510 Chr 19 q13.33 Yes  Yes 27368346, 22081015 
ZNF524 ENSG00000171443 ENSP00000301073 Chr 19 q13.42     
ZNF653 ENSG00000161914 ENSP00000293771 Chr 19 p13.2     
KMT2B ENSG00000272333 ENSP00000398837 Chr 19 q13.12 Yes   27368346 
PHF20 ENSG00000025293 ENSP00000363124 Chr 20 q11.22   Yes 22081015 
PATZ1 ENSG00000100105 ENSP00000266269 Chr 22 q12.2     
MECP2 ENSG00000169057 ENSP00000301948 Chr X q28   Yes 22081015, 23023293 
 
  
 
TABLE S7: NAME, SEQUENCE, AND PURPOSE OF OLIGONUCLEOTIDE PRIMERS USED IN THIS STUDY 
Primer name Sequence (5’ to 3’) Purpose 
Xrp Del FW1 GCGCAGTTTCTTCCAGCGAC 
Verification of Xrp1Ex-long 
Xrp Del FW2 TCAAGGCCAATCGCAAAGTG 
Xrp Del REV1 CGGCGCAACAAGTTAGAAGG 
Xrp Del REV2 ACACCTCTTAACGCTGCAAC 
CG14291 Del FW1 GTGCGTCCAGATTGGGAGTTTG 
Verification of Df(3R)Xrp1Plus 
CG14291 Del FW2 CCGAGGTGAAGGCGTTGTTG 
CG42613 Del REV1 TGTACTTCGGAGCCCGTTCG 
CG42613 Del REV2 TTATACTCCTCGTCGGCAAC 
Xrp1 Long EagI FW GCTACGGCCGATGATCCAGGAGCCAGC Generation of Xrp1Long 
Xrp1 short NotI FW GCTAGCGGCCGCATGTTTGCCGAGGAGGATC Generation of Xrp1Short 
Xrp1 XhoI REV GCTACTCGAGTCAGTCCTGCTCCTGCTTA Generation of Xrp1Long and Xrp1Short 
caz FW CAACGACATGATCACCCAGG 
Quantitation of caz mRNA 
caz REV CATTGGTGTCGTCGTAGGTG 
Xrp1 Sh Junc FW1 ATGATCGGTTCGAGGCTCC 
Quantitation of total Xrp1 mRNA 
Xrp1 Sh Junc REV1 ATCCTCTACGATGTCTGCATGG 
Xrp1 Long FW TTGAAGAGATAGACGTTCCGGTG 
Quantitation of Xrp1 Long mRNA 
Xrp1 Long REV AGATCCTCCTCGGCAAACATG 
rp49 FW CCAGTCGGATCGATATGCTAA 
Quantitation of rp49 control mRNA 
rp49 REV ACCGTTGGGGTTGGTGAG 
EifTuM FW CATGTCCTTCATCCAACTGCA 
Quantitation of EifTuM control mRNA 
EifTuM REV AATGAGCTTGGTGTCTTCGCC 
Xrp1_LHA_FW 
AGTCAAGCTTCAAAACGTCGTGAGACAGTTTGAACAGCTGTT
GCAACGTGTGG 
Amplification of left homology arm for 
Xrp1 gene targeting 
Xrp1_LHA_REV AGTCGAATTCAGTATTGTTACTAACTGACTCAACTGCGAGC 
Xrp1_RHA_FW AGTCGAATTCCGTAGCCATAGAATAGAAATTGCGGAGC Amplification of right homology arm for 
Xrp1 gene targeting 
Xrp1_RHA_Rev 
AGTCGGTACCATTACCCTGTTATCCCTAGCAGCAGGCGTAAA
TGTAATCCTTGC 
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Figure S1. Generation and characterization of Xrp1 mutant and transgenic lines. (A) Schematic representation of the Xrp1 genomic locus and the seven 
predicted Xrp1 transcripts (Xrp1-RA to Xrp1-RG) encoding either the short or long Xrp1 isoform. ORFs are colored orange; 5′ and 3′ UTRs are colored gray. (B) 
Efficiency of Xrp1 knockdown by transgenic RNAi expression. Real-time qPCR was used to quantify total Xrp1 transcript levels in the CNS of third instar lar-
vae. Control animals (driver only) were compared with animals ubiquitously (actin5C-GAL4) expressing either of the two UAS-Xrp1-RNAi transgenes used in 
this study. Expression levels relative to control (100%) are shown. n = 8 (control), 5 (Xrp1-RNAi-1), and 7 (Xrp1-RNAi-2). **, P < 0.01; one-way ANO VA. Mean 
± SEM. (C) Strategy used for generation of the Xrp1KO allele: (1) Xrp1 genomic region with the insertion site of the Mi{MIC}07118 transposable element indi-
cated. The sequences used as left and right homology arms (LHAs and RHAs, respectively) are underlined. (2) Magnification of the Mi{MIC} element with 
flanking Xrp1 sequences. The targeting vector used for recombination-mediated cassette exchange (RMCE) contains the left homology arm, preceded by an 
I-SceI restriction site, and the right homology arm, followed by an I-CreI restriction site, and flanked by attB recombination sites. (3) PhiC31 recombinase 
mediates recombination between the attP sites in the Mi{MIC} element and the attB sites in the targeting vector, resulting in exchange of the Mi{MIC} cas-
sette by the targeting cassette. (4) Crossing with an I-SceI transgenic line results in a DNA double-strand break at the I-SceI site, and (5) in vivo homologous 
recombination between left homology arm sequences results in precise deletion of the Xrp1 coding region left of the Mi{MIC} element. (6) Crossing with an 
I-CreI transgenic line results in a DNA double-strand break at the I-CreI site, and (7) in vivo homologous recombination between right homology arm se-
quences results in precise deletion of the Xrp1 coding region right of the Mi{MIC} element. (D–F) The RGR-to-AAA mutation in the AT-hook motif does not 
reduce, but rather increases, the stability of the Xrp1 protein. (D) Drosophila S2 cells were cotransfected with a plasmid encoding actin5C-GAL4 and plasmids 
encoding N-terminal HA-tagged Xrp1 (short isoform), either WT or AT-hook mutant (Mut). Cells transfected with the actin5C-GAL4 plasmid alone were used 
as controls. Western blotting on protein extracts with antibodies against the HA-tag and β-tubulin (loading control) is shown. (E) WT or AT-hook mutant 
HA::Xrp1Short was selectively expressed in motor neurons (OK371-GAL4) from UAS transgenes inserted in the same genomic landing site (VK31). Protein ex-
tracts from third instar larval CNS were used for Western blotting, using the same antibodies as in D. Driver-only animals were used as controls. (F) Quanti-
fication of HA::Xrp1Short protein levels relative to β-tubulin in Western blots shown in E. Data are shown as percentages of UAS-Xrp1Short WT. n = 5. P = 0.006 
by one-way ANO VA.
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Figure S2. Heterozygosity for Xrp1 does not rescue the adult eclosion defect of TBPH mutant flies. (A) Bar graph showing the relative frequency of 
adult F1 offspring for the indicated cross, using the TBPHΔ23 and TBPHΔ142 alleles. The offspring frequency of crosses between +/CyO males and females 
is shown as control. Since homozygous CyO flies die during development, the theoretically expected offspring frequency is 66.6% TBPHΔ/CyO and 33.3% 
TBPHΔ/TBPHΔ. The adult offspring frequency of TBPHΔ23/TBPHΔ142 flies is significantly reduced. (B) Relative frequency of adult non-CyO F1 offspring for 
the indicated cross. The theoretically expected offspring frequency is 50% TM6B/+ and 50% Df(3R)Xrp1Plus/+. In control crosses, females carry a WT chro-
mosome instead of Df(3R)Xrp1Plus. Thus, heterozygosity for Xrp1 does not rescue TBPH mutant developmental lethality. Statistical analysis was per-
formed using χ2 test.
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Figure S3. Cazmutant larval motor defects are rescued by Xrp1 heterozygosity or selective Xrp1 knockdown in motor neurons, and a subtle muta-
tion in the Xrp1 AT-hook motif affects Xrp1 chromatin binding. (A) Reduced crawling speed of caz mutant larvae is rescued by heterozygosity for Xrp1 or 
a genomic caz transgene. n = 30–90. ***, P < 0.0005; one-way ANO VA. (B) Selective knockdown of Xrp1 in motor neurons (D42-GAL4) is sufficient to rescue 
the caz mutant locomotion defect. n = 90. ***, P < 5 × 10−7; one-way ANO VA. (C) A subtle mutation in the AT-hook motif alters the binding pattern of Xrp1 to 
polytene chromosomes. WT (middle) or AT-hook mutant (bottom) Xrp1Short with N-terminal HA-tag was transgenically expressed in larval salivary glands. 
Anti-HA immunostaining revealed Xrp1 binding to polytene chromosomes, and DAPI was used to visualize banding patterns. Driver-only control (top) con-
firms specificity of the anti-HA antibody. Bar, 20 µm.
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Figure S4. Characterization of the caz-Xrp1 genetic interaction. (A) Selective knockdown of Xrp1 in glial cells does not rescue caz mutant pupal lethality. 
Relative frequency of adult male F1 offspring from the indicated cross is shown for two independent UAS-Xrp1-RNAi lines. No adult caz2 males were de-
tected, even in the presence of the repo-GAL4 driver to knock down Xrp1 selectively in glial cells. Note that a similar frequency of hemizygous FM7 males 
with or without panglial Xrp1 knockdown was found, showing that Xrp1 knockdown in glial cells does not induce developmental lethality. n > 81 per geno-
type. (B and C) Xrp1 expression is up-regulated in both CNS and body wall of caz mutant animals. Real-time qPCR was used to quantify total Xrp1 transcript 
levels in the CNS (B) and body wall (C) of third instar larvae, either WT or caz2. Expression levels relative to WT (100%) are shown. n = 8. ***, P < 0.001; 
two-tailed unpaired t test. Mean ± SEM. (D–F) Selective neuronal Xrp1 overexpression phenocopies caz mutant phenotypes. (D) Relative frequency of adult 
female F1 offspring from the indicated cross that is heterozygous for either the balancer or UAS transgenes expressing the short or long Xrp1 isoforms. Neu-
ron-selective (elav-GAL4) Xrp1Long overexpression induces developmental lethality. n > 144 per genotype. (E) Average climbing speed of adult female flies 
selectively overexpressing Xrp1Short in neurons (elav-GAL4) as compared with control (driver only) flies. n > 100 per genotype. ***, P < 10−9; Mann-Whitney 
test. (F) Life span of female flies selectively overexpressing short or long Xrp1 isoforms in neurons (elav-GAL4) as compared with control (driver only) flies. 
n = 26–189 per genotype. (G and H) Coimmunoprecipitation experiments indicate that Xrp1 does not form homodimers. Drosophila S2 cells were transfected 
with a plasmid encoding actin5C-GAL4 and different combinations of plasmids encoding N-terminal HA- or Flag-tagged Xrp1. Protein extracts were either 
directly used for Western blotting (WB) with anti-HA or anti-Flag antibodies (input [I] lanes) or immunoprecipitated with anti-HA antibody followed by West-
ern blotting (immunoprecipitation [IP] lanes). Similar experiments were performed for the short (G) and long (H) Xrp1 isoforms. In both cases, immunopre-
cipitation of HA-tagged Xrp1 did not result in coimmunoprecipitation of Flag-tagged Xrp1. (I) Caz does not coimmunoprecipitate with Xrp1. Drosophila S2 
cells were cotransfected with a plasmid encoding actin5C-GAL4 and plasmids encoding N-terminal HA-tagged Xrp1, either the short or the long isoform. Cells 
transfected with the actin5C-GAL4 plasmid alone were used as control. Protein extracts were prepared and used for immunoprecipitation with anti-HA an-
tibodies. Western blotting of immunoprecipitates and 5% of original extracts (input) was performed using anti-HA or anti-Caz antibodies.
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Figure S5. Heterozygosity for Xrp1 mitigates gene expression dysregulation in caz mutant CNS. (A) Principal component analysis plot for all samples 
included in the RNA-seq analysis (red dots, cazKO; purple dots, Df(3R)Xrp1Plus/+; green dots, cazKO;;Df(3R)Xrp1/+; blue dots, w1118). The principal component 
analysis procedure performs an orthogonal transformation on the data to convert the observed gene expression values in each sample into a set of values of 
variables linearly uncorrelated known as principal components (PCs). This transformation is defined so that the first principal component explains the largest 
possible variance. The plot displays the distribution of the samples according to the first two principal components, which overall explain 58% of the variance 
found in the data. The percentage of variance explained by the rest of principal components is displayed as a cumulative bar plot underneath the principal 
component analysis plot. (B) Unsupervised hierarchical clustering of all RNA-seq samples. Entries in the matrix are color-coded according to the Manhattan 
distance between samples. The dendrograms in the margins represent linkage distance between clusters. (C) Distribution of RPKM values for caz (left) and 
Xpr1 (right) across all samples. RPKM values for each replicate are represented as solid dots. Horizontal lines indicate the mean value for each condition. (D) 
Top 10 enriched GO terms (Molecular Function ontology) in the cazKO versus w1118 comparison for the set of up-regulated (red) and down-regulated genes 
(blue). (E) Correlation analysis of the log2 fold change values obtained from the RNA-seq analysis and qPCR-derived ΔΔCt values for a panel of 19 genes. Each 
plot displays the regression line (solid blue), 95% confidence interval (gray shadow), and R2 values. Error bars indicate SEM.
Mallik et al. 
Xrp1 mediates caz mutant phenotypes
Journal of Cell Biology
https://doi.org/10.1083/jcb.201802151
S25
Table S1 is a separate PDF showing human homologs of Xrp1.
Table S2 is a separate Excel file showing Xrp1Long-interacting proteins ranked according to fold enrichment.
Table S3 is a separate Excel file showing Xrp1Short-interacting proteins ranked according to fold enrichment.
Table S4 is a separate Excel file showing Caz-interacting proteins ranked according to fold enrichment.
Table S5 is a separate Excel file showing a list of RNA-seq results for each gene from the DESeq2 analysis.
Table S6 is a separate PDF showing human genes encoding AT-hook proteins, including gene name, Ensemble Gene ID, Ensemble 
Protein ID, and chromosomal location.
Table S7 is a separate PDF showing name, sequence, and purpose of oligonucleotide primers used in this study.
